32
Views
4
CrossRef citations to date
0
Altmetric
Research Article

Intraperitoneal implant of recombinant encapsulated cells overexpressing alpha-l-iduronidase partially corrects visceral pathology in mucopolysaccharidosis type I mice

, , , , , , , & show all
Pages 860-867 | Received 11 Jan 2012, Accepted 27 Feb 2012, Published online: 03 Apr 2012

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (4)

Roberto Giugliani, Andressa Federhen, Filippo Vairo, Cláudia Vanzella, Gabriela Pasqualim, Letícia Machado Rosa da Silva, Luciana Giugliani, Ana Paula Kurz de Boer, Carolina Fishinger Moura de Souza, Ursula Matte & Guilherme Baldo. (2016) Emerging drugs for the treatment of mucopolysaccharidoses. Expert Opinion on Emerging Drugs 21:1, pages 9-26.
Read now
Guilherme Baldo, Roberto Giugliani & Ursula Matte. (2014) Gene delivery strategies for the treatment of mucopolysaccharidoses. Expert Opinion on Drug Delivery 11:3, pages 449-459.
Read now
Valeska Lizzi Lagranha, Talita Giacomet de Carvalho, Roberto Giugliani & Ursula Matte. (2013) Treatment of MPS I mice with microencapsulated cells overexpressing IDUA: effect of the prednisolone administration. Journal of Microencapsulation 30:4, pages 383-389.
Read now
Roberto Giugliani, Andressa Federhen, André Anjos Silva, Camila Matzenbacher Bittar, Carolina Fischinger Moura de Souza, Cristina Brinckmann Oliveira Netto, Fabiana Quoos Mayer, Guilherme Baldo & Ursula Matte. (2012) Emerging treatment options for the mucopolysaccharidoses. Research and Reports in Endocrine Disorders 2, pages 53-64.
Read now

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.